Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Future Virol. 2015 Jun;10(6):715–730. doi: 10.2217/fvl.15.31

Table 1.

Influenza vaccines.

Characteristics Current FDA-approved vaccines
New vaccines
IIV LAIV RIV CPB/CB
Safety ++ + ++ ++

Immunogenicity + ++ + ++

Humoral response Yes Yes Yes Yes

Cellular response Weak Yes Weak Yes

Manufacturing
method
Egg-based production Tissue culture (insect) Tissue culture (mammalian)

CB: Codon bias; CPB: Codon pair bias; IIV: Inactivated influenza vaccine; LAIV: Live attenuated influenza vaccine; RIV: Recombinant influenza vaccine.